A long-standing bureaucratic obstacle to privately-funded medical marijuana research has just been removed, effective immediately. The Department of Health and Human Services determined that the PHS review process is...
During its 2014 session, the Alabama Legislature passed a law authorizing a state-sponsored study of the efficacy of CBD in treating seizure disorders. Advocates of medicinal cannabis in...
Ontario, Canada: The administration of nabilone, a synthetic cannabinoid, safely mitigates symptoms of post-traumatic stress (PTS) syndrome, according to clinical data published online ahead of print in the Journal of Psychopharmacology....
The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a...
British drug maker GW Pharmaceuticals released the first results on the efficacy and safety of Epidiolex, a purified form of the marijuana compound cannabidiol (CBD), on Tuesday. The...
Newly discovered documents from tobacco company archives at UC San Francisco show that major companies in the cigarette industry investigated joining the marijuana business in the late...
Earlier this year, Kentucky law makers passed a bill (with incredible cooperation and speed, relatively speaking) that would allow for the first legally approved medicinal use of...
This month, newly FDA-approved, crazy-strong painkiller Zohydro ER is set to be released to market. Commonly referred to as “heroin in a bottle,” Zohyrdo ER has received staunch opposition from...
Some of issues stalling trials in Kentucky are the availability of marijuana oil, the possible need for approval from the Food and Drug Administration and the cost of...
Patients who use medical marijuana for pain and other chronic symptoms can take an unwanted hit: Insurers don’t cover the treatment, which costs as much as $1,000...
Lawmakers in Alabama and Utah recently approved legislation seeking to authorize the physician-supervised use of varieties of cannabis and/or extracts high in the non-psychotropic cannabinoid cannabidiol (CBD). Both measures,...
At a public signing ceremony today, Utah’s Republican Gov. Gary Herbert will approve House Bill 105 — aka “Charlee’s Law.” The law, and others like it, ostensibly allows children...
The LA Times reports that the Obama administration handed backers of medical marijuana a significant victory last Friday, opening the way for a University of Arizona researcher to examine whether cannabis...
New Scientific Review of Epilepsy and Medical Marijuana Provides Scientific Foundation for Dr. Sanjay Gupta’s Claims “Cannabis in the Treatment of Epilepsy” comes as demand grows for...
Thousands of veterans and other medical marijuana patients nationwide use marijuana to treat symptoms of PTSD, but the U.S. Public Health Service (PHS) is blocking researchers who...
The Epilepsy Foundation comes out in support of medical marijuana, the feds delay a PTSD study, CBD bills are popping up, and a battle over local dispensary...
NORML and NORML Foundation are supported by cannabis consumers and other caring citizens. Please see our annual report and help us to keep going strong into 2014 by making...
The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric...
